Vertex seeks to mobilise Sh5 billion for the Bond Fund through the issuance of 50 million units, and a further Sh5 billion for the Exchange Traded Fund via an Initial Public Offering of ETF shares ...

Vertex SME Holdings Limited, a private equity vehicle managed by JMMB Securities Limited, is gearing up to raise another $1 billion to fund its pipeline of investment opportunities. Private equity ...

All eligible people with CF in England can now benefit from this medicine -  LONDON - July 15, 2025 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a ...

LONDON, July 14, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad reimbursement agreement with NHS England for Vertex’s cystic fibrosis (CF ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the financial market ...

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years and older.

Vertex Pharmaceuticals: 2025 TIME100 Most Influential CompaniesBoston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR ...

Vertex had plans to hire 1,300 employees in Wilmington, but it never even got close.

Vertex's pipeline is poised to produce other big winners. I don't just think Vertex is a stock to buy on the dip -- I think it's a screaming buy. Keith Speights has positions in Vertex ...

Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped.